LBTSF News and Press, Almirall Sa Ord From 11/10/22

Almirall, S.A. press release ( OTCPK:LBTSF ): Q3 Non-GAAP EPS of €0.18. Revenue of €633.8M (+5.3% Y/Y). For further details see: Almirall, S.A. Non-GAAP EPS of €0.18, revenue of €633.8M

Summary Beijing YishengBio will merge with a SPAC vehicle, Summit Healthcare Acquisition, to list on the Nasdaq Exchange at a pre-money equity value of $834 million. Simcere Pharma of Nanjing announced a $507 million out-licensing to Spain’s Almirall for ex-China rights to ...

Almirall, S.A. (LBTSF) Q2 2022 Results Earnings Conference Call July 25, 2022, 04:00 AM ET Company Participants Pablo Divasson del Fraile - Director of Investor Relations, Shareholders and ESG Gianfranco Nazzi - Chief Executive Officer Karl Ziegelbauer - Executiv...

The following slide deck was published by Almirall, S.A. in conjunction with their 2022 Q2 earnings call. For further details see: Almirall, S.A. 2022 Q2 - Results - Earnings Call Presentation

Almirall achieves Core Net Sales growth of 5.1% to 436.6 MM Euros in H1 PR Newswire Strong operational performance during the first half of the year. The business continues to perform well boosted by the growth in Core Net Sales (+5.1% year-on-year) from key products...

Evotec (OTCPK:EVOTF) (NASDAQ:EVO) and Almirall (OTC:LBTSF) are collaborating to discover therapies for severe skin diseases. Under the agreement, Evotec will get an undisclosed upfront payment, research payments, and success-based milestones of potentially up to €230M per program and r...

Almirall, S.A. (LBTSF) Q1 2022 Earnings Conference Call May 9 2022 4:00 AM ET Company Participants Carlos Gallardo Piqué - Chairman and President Gianfranco Nazzi - Chief Executive Officer Mike McClellan - Chief Financial Officer Karl Ziegelbauer - Chief Scientific Officer Pablo Divasson...

Almirall delivers good business performance in Q1 and reiterates full year 2022 guidance PR Newswire BARCELONA, Spain , May 9, 2022 /PRNewswire/ -- Good start to the year with Core Net Sales* at €218.8 MM (+1.6% year-on-year) driven by recently lau...

Almirall, S.A. press release (OTC:LBTSF): FY Normalised Net Income was €81.4M. Revenue of €836.5M (+2.7% Y/Y). Core Net Sales reached €809.8M, a 7.2% year-on-year increase. Core EBITDA of €211.3 MM (+17% Y/Y). 2022 Full Year Guidance: ...

Almirall, S.A. (LBTSF) Q4 2021 Earnings Conference Call February 21, 2022 4:00 AM ET Company Participants Pablo Divasson - Head of Investor Relations Gianfranco Nazzi - Chief Executive Officer Karl Ziegelbauer - Chief Scientific Officer Mike McClellan - Chief Financial Officer Conference Call...